Dual-target inhibitors of cholinesterase and GSK-3β to modulate Alzheimer’s disease
Junqiu He, Kin Yip Tam
Topics & Concepts
GSK-3CholinesteraseDiseaseDrug discoveryGalantamineAlzheimer's diseasePharmacologyCholinergicNeuroscienceMedicineBiopharmaceuticalDonepezilBioinformaticsBiologyKinaseBiochemistryInternal medicineDementiaBiotechnologyCholinesterase and Neurodegenerative DiseasesComputational Drug Discovery MethodsNicotinic Acetylcholine Receptors Study